Evidence map›Paper›PMID 34821749›Full record

ArticleBioengineering (Basel, Switzerland)2021

Design and Analysis of a Biodegradable Polycaprolactone Flow Diverting Stent for Brain Aneurysms.

Kaitlyn Tidwell, Seth Harriet, Vishal Barot, Andrew Bauer, Melville B Vaughan, Mohammad R Hossan

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kaitlyn TidwellDepartment of Engineering and Physics, University of Central Oklahoma, Edmond, OK 73034, USA.
Seth HarrietDepartment of Engineering and Physics, University of Central Oklahoma, Edmond, OK 73034, USA.
Vishal BarotDepartment of Engineering and Physics, University of Central Oklahoma, Edmond, OK 73034, USA.ORCID 0000-0002-0138-5059
Andrew BauerDepartment of Neurosurgery, University of Oklahoma-Health Science Center, Oklahoma City, OK 73104, USA.
Melville B VaughanDepartment of Biology, University of Central Oklahoma, Edmond, OK 73034, USA.ORCID 0000-0003-4648-6141
Mohammad R HossanDepartment of Engineering and Physics, University of Central Oklahoma, Edmond, OK 73034, USA.ORCID 0000-0002-4598-9671
University of Central Oklahoma · USUniversity of Oklahoma Health Sciences Center · US

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Mark L Lang · 2012 to 2026
$60.2M
NIGMS NIH HHS P20 GM103447NIH HHS P20GM103447
6 · The paper itself

Abstract

The flow diverting stent (FDS) has become a promising endovascular device for the treatment of aneurysms. This research presents a novel biodegradable and non-braided Polycaprolactone (PCL) FDS. The PCL FDS was designed and developed using an in-house fabrication unit and coated on two ends with BaSO

Indexed as

aneurysmsbiodegradableendovascular treatmentflow diverting stents (FDS)Polycaprolactone (PCL) flow diverters

Identifiers

PMID34821749
PMCPMC8614946
OpenAlexW3213916450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.